Off-label Marketing and Free Speech: Caronia and the Future of Speech in Therapeutic Product Promotion

    Off-label Marketing and Free Speech: Caronia and the Future of Speech in Therapeutic Product Promotion
    CLE 90 min

    Off-label Marketing and Free Speech: Caronia and the Future of Speech in Therapeutic Product Promotion

    • The download and on-demand online course for this title will be available for ABA Value Pass subscribers.
    • CD-ROM available to order 3 weeks before the program. Online courses and downloads will be available about a week after the program.
    • Recording date: Wednesday, November 12, 2014
    • Product Code: CE1411OMFUMB
    *Additional discounts may apply at checkout

    Log In to view your rate

    The landmark decision in U.S. v. Caronia has emboldened drugs and biologics makers to contest charges of off-label marketing, including the currently pending California False Claims Act case regarding unapproved uses of Integrilin. This program will focus on Caronia and other First Amendment cases, including IMS Health Inc. v. Sorrell, evaluating the prosecution of off-label promotion against the therapeutic products industries.

    In this program, our esteemed faculty will:

    • Provide you with key factual and procedural information regarding Caronia and related First Amendment cases to provide discussion context
    • Present and assess government and industry perspectives to the litigation and future impacts
    • Discuss how the cases may practically impact current and future prosecutions as well as actions taken by therapeutic product companies

    Product Details

    Moderators

    Colleen Heisey

    Panelists

    Geoffrey Kaiser, Ralph Hall

    Sponsors

    ABACLE, Health Law Section

    Product Code

    CE1411OMFUMB

    Duration

    90

    Publication Date

    11/12/2014 12:00:00 AM

    Related On-Demand CLE

    Related Events